| Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis DM Black, PD Delmas, R Eastell, IR Reid, S Boonen, JA Cauley, ... New England Journal of Medicine 356 (18), 1809-1822, 2007 | 3984 | 2007 |
| Zoledronic acid and clinical fractures and mortality after hip fracture KW Lyles, CS Colón-Emeric, JS Magaziner, JD Adachi, CF Pieper, ... New England Journal of Medicine 357 (18), 1799-1809, 2007 | 2546 | 2007 |
| Identification of late-onset hypogonadism in middle-aged and elderly men FCW Wu, A Tajar, JM Beynon, SR Pye, AJ Silman, JD Finn, TW O'Neill, ... New England Journal of Medicine 363 (2), 123-135, 2010 | 1771 | 2010 |
| Romosozumab treatment in postmenopausal women with osteoporosis F Cosman, DB Crittenden, JD Adachi, N Binkley, E Czerwinski, S Ferrari, ... New England Journal of Medicine 375 (16), 1532-1543, 2016 | 1629 | 2016 |
| Meta-analysis: excess mortality after hip fracture among older women and men P Haentjens, J Magaziner, CS Colón-Emeric, D Vanderschueren, ... Annals of internal medicine 152 (6), 380-390, 2010 | 1623 | 2010 |
| Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis KG Saag, R Emkey, TJ Schnitzer, JP Brown, F Hawkins, S Goemaere, ... New England Journal of Medicine 339 (5), 292-299, 1998 | 1612 | 1998 |
| Romosozumab in postmenopausal women with low bone mineral density MR McClung, A Grauer, S Boonen, MA Bolognese, JP Brown, ... New England Journal of Medicine 370 (5), 412-420, 2014 | 1324 | 2014 |
| Effect of 6‐month whole body vibration training on hip density, muscle strength, and postural control in postmenopausal women: a randomized controlled pilot study SMP Verschueren, M Roelants, C Delecluse, S Swinnen, ... Journal of bone and mineral research 19 (3), 352-359, 2004 | 1272 | 2004 |
| IOF position statement: vitamin D recommendations for older adults B Dawson-Hughes, A Mithal, JP Bonjour, S Boonen, P Burckhardt, ... Osteoporosis international 21 (7), 1151-1154, 2010 | 1210 | 2010 |
| Efficacy and safety of balloon kyphoplasty compared with non-surgical care for vertebral compression fracture (FREE): a randomised controlled trial D Wardlaw, SR Cummings, J Van Meirhaeghe, L Bastian, JB Tillman, ... The Lancet 373 (9668), 1016-1024, 2009 | 1133 | 2009 |
| Teriparatide or alendronate in glucocorticoid-induced osteoporosis KG Saag, E Shane, S Boonen, F Marín, DW Donley, KA Taylor, GP Dalsky, ... New England Journal of Medicine 357 (20), 2028-2039, 2007 | 1099 | 2007 |
| Hypothalamic-pituitary-testicular axis disruptions in older men are differentially linked to age and modifiable risk factors: the European Male Aging Study FCW Wu, A Tajar, SR Pye, AJ Silman, JD Finn, TW O'Neill, G Bartfai, ... The Journal of Clinical Endocrinology & Metabolism 93 (7), 2737-2745, 2008 | 1093 | 2008 |
| Interspecies Differences in Bone Composition, Density, and Quality: Potential Implications for in Vivo Bone Research J Aerssens, S Boonen, G Lowet, J Dequeker Endocrinology 139 (2), 663-670, 1998 | 1064 | 1998 |
| Canadian normative data for the SF-36 health survey WM Hopman, T Towheed, T Anastassiades, A Tenenhouse, S Poliquin, ... Cmaj 163 (3), 265-271, 2000 | 993 | 2000 |
| Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis JD Adachi, WG Bensen, J Brown, D Hanley, A Hodsman, R Josse, ... New England Journal of Medicine 337 (6), 382-388, 1997 | 949 | 1997 |
| Androgens and bone D Vanderschueren, L Vandenput, S Boonen, MK Lindberg, R Bouillon, ... Endocrine reviews 25 (3), 389-425, 2004 | 920 | 2004 |
| The effect of 3 versus 6 years of zoledronic acid treatment of osteoporosis: a randomized extension to the HORIZON‐Pivotal Fracture Trial (PFT) DM Black, IR Reid, S Boonen, C Bucci‐Rechtweg, JA Cauley, F Cosman, ... Journal of bone and mineral research 27 (2), 243-254, 2012 | 832 | 2012 |
| Need for additional calcium to reduce the risk of hip fracture with vitamin D supplementation: evidence from a comparative metaanalysis of randomized controlled trials S Boonen, P Lips, R Bouillon, HA Bischoff-Ferrari, D Vanderschueren, ... The Journal of Clinical Endocrinology & Metabolism 92 (4), 1415-1423, 2007 | 789 | 2007 |
| Efficacy of raloxifene on vertebral fracture risk reduction in postmenopausal women with osteoporosis: four-year results from a randomized clinical trial PD Delmas, KE Ensrud, JD Adachi, KD Harper, S Sarkar, C Gennari, ... The Journal of Clinical Endocrinology & Metabolism 87 (8), 3609-3617, 2002 | 784 | 2002 |
| Two‐year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids: a randomized, double‐blind, placebo‐controlled extension trial JD Adachi, KG Saag, PD Delmas, UA Liberman, RD Emkey, E Seeman, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2001 | 727 | 2001 |
